Biome Australia reports optimistic outlook after sales surge 70 per cent

 Biome Australia (ASX: BIO) is gathering momentum after seeing sales of its probiotics, plant-based supplements and sports supplements surge by 70 per cent to $1.56 million in the first quarter of FY23, leading to expectations the biotherapeutics company will generate $7 million by the end of the fiscal year.

If the forecast transpires it will represent a 69.9 per cent growth rate, compared to a 78 per cent uplift to $4.12 million in FY22. 

While Biome operated at a $4.5 million loss in the previous financial year, this is still an improvement on the $5.3 million loss recorded in FY21. 

Read More: https://www.businessnewsaustralia.com/articles/biome-australia-reports-optimistic-outlook-after-sales-surge-by-70pc.html